Organization

Polish Mother's Memorial Hospital - Research Institute

2 abstracts

Abstract
Real-world treatment outcomes in patients with HR+ HER2- advanced breast cancer treated with CDK4/6 inhibitors and endocrine therapy.
Org: Military Institute of Medicine-National Research Institute, Department of Oncology, National Taiwan University Hospital, Department of Clinical Oncology, Queen Elizabeth Hospital, Breast Unit, Lower Silesian Oncology Centre,
Abstract
Safety, pharmacokinetics and anti-tumor activity of RP12146, a PARP1/2 inhibitor, in patients with locally advanced or metastatic solid tumors.
Org: Jagiellonian University Hospital, Kraków, Poland, Kraków University Hospital, Krakow, Poland, Polish Mother's Memorial Hospital - Research Institute,